B-hCG Expression in Bladder Cancers
Author Information
Author(s): Ray Iles
Primary Institution: St Bartholomew's Hospital Medical College
Hypothesis
Does B-hCG expression correlate with the prognosis of bladder cancer?
Conclusion
B-hCG screening is not a reliable marker for bladder disease, but its expression is linked to poor prognosis.
Supporting Evidence
- Only 4% of patients with limited disease had elevated serum B-hCG levels.
- 76% of patients with widespread metastatic disease had elevated serum B-hCG levels.
- Elevated urinary B-hCG was found in several patients across different stages of disease.
- B-hCG expression is associated with poorly differentiated tumors.
- Detection of B-hCG may indicate an aggressive cancer phenotype.
Takeaway
Doctors looked at a hormone called B-hCG in bladder cancer patients. They found that when this hormone is present, it usually means the cancer is more serious.
Methodology
Blood and urine samples were collected from patients and tested for B-hCG levels.
Potential Biases
Potential sampling error in detecting B-hCG expression.
Limitations
The stages of disease were not fully documented in the referenced studies.
Participant Demographics
Patients attending the Urology Department of the Royal London Hospital between 1986 and 1988.
Want to read the original?
Access the complete publication on the publisher's website